IL-4Rα polymorphism in regulation of IL-4 synthesis by T cells: Implication in susceptibility to a subset of murine lupus

International Immunology

Volumn 19, Issue 2, 2007, Pages 175-183

  Shiroiwa, Wakana ^a   Tsukamoto, Kazuyuki ^a   Ohtsuji, Mareki ^a   Lin, Qingshun ^a   Ida, Akinori ^a   Kodera, Sanki ^a   Ohtsuji, Naomi ^a   Nakamura, Kazuhiro ^a   Tsurui, Hiromichi ^a   Kinoshita, Katsuyuki ^a   Nishimura, Hiroyuki ^b   Shirai, Toshikazu ^a   Hirose, Sachiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOIN UNIVERSITY OF YOKOHAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 4 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD3; CELL SURFACE RECEPTOR; IL4RA PROTEIN, MOUSE; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 7; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; PROTEINURIA; QUANTITATIVE TRAIT LOCUS; SPLEEN; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; NEW ZEALAND BLACK MOUSE; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; INTERLEUKIN-4; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED NZB; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TH2 CELLS;

EID: 33846639186     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl134     Document Type: Article

References (52)

1. + T-cells. Annu. Rev. Immunol. 12:635.
2. Yoshimoto, T. and Paul, W. E. 1994. CD4pos, NK1.1pos T-cells promptly produce interleukin-4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
3. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paul, W. E. 1999. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701.
4. Mosmann, T. R. and Coffman, R. L. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
5. Powrie, F. and Coffman, R. L. 1993. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol. Today 14:270.
6. Kondo, M., Takeshita, T., Ishii, N. et al. 1993. Sharing of the interleukin 2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874.
7. Hershey, G. K., Friedrich, M. F., Esswein, L. A., Thomas, M. L. and Chatila, T. A. 1997. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N. Engl. J. Med. 337:1720.
8. Mitsuyasu, H., Izuhara, K., Mao, X.-Q. et al. 1998. Ile50Val variant of IL-4Ralpha upregulates IgE synthesis and associates with atopic asthma. Nat. Med. 9:119.
9. Mitel, D. B., Valdes, A. M., Lazzeroni, L. C., Reynolds, R. L., Erlich, H. A. and Noble, J. A. 2000. Association of IL-4R haplotypes with type I diabetes. Diabetes 51:3336.
10. Steck, A. K., Bugawan, T. L., Valdes, A. M. et al. 2005. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes 54:2482.
11. Mirel, D. B., Barcellos, L. F., Wang, J., Hauser, S. L., Oksenberg, J. R. and Erlich, H. A. 2004. Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun. 5:138.
12. Kanemitsu, S., Takabayashi, A., Sasaki, Y. et al. 1999. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis Rheum. 42:1298.
13. Schulte, T., Kurrle, R., Röllinghoff, M. and Gessner, A. 1997. Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes. J. Exp. Med. 186:1419.
14. Baker, D., Rasenwasser, O. A., O'Neill, J. K. and Turk, J. L. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155:4046.
15. Hang, L. M., Izui, S. and Dixon, F. J. 1981. (NZW × BXSB) F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 154:216.
16. Ida, A., Hirose, S., Hamano, Y. et al. 1998. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW × BXSB) F1 mice. Eur. J. Immunol. 28:2694.
17. Kuchroo, V. K., Umetsu, D. T., DeKruyff, R. H. and Freeman, G. J. 2003. The TIM gene family: Emerging roles in immunity and disease. Nat. Rev. Immunol. 3:454.
18. Wills-Karp, M., Belkaid, Y. and Karp, C. L. 2003. I-Tim-izing the pathways of counter-regulation. Nat. Immunol. 4:1050.
19. McIntire, J. J., Umetsu, S. E., Akbari, O. et al. 2001. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:1109.
20. +T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
21. + T-cell subsets in autoimmnity. Curr. Opin. Immunol. 9:872.
22. Hill, N. and Sarvetnick, N. 2002. Cytokines: Promotes and dampeners of autoimmunity. Curr. Opin. Immunol. 14:791.
23. Nakajima, A., Hirose, S., Yagita, H. and Okumura, K. 1997. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158:1466.
24. Kono, D. H., Balomenos, D., Park, M. S. and Theofilopoulos, A. N. 2000. Development of lupus in BXSB mice is independent of IL-4. J. Immunol. 164:38.
25. Howie, J. B. and Helyer, B. J. 1968. The immunology and pathology of NZB mice. Adv. Immunol. 9:215.
26. Wofsy, D. and Seaman, W. E. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378.
27. Sekigawa, I., Ishida, Y., Hirose, S., Sato, H. and Shirai, T. 1986. Cellular basis of in vitro anti-DNA antibody production: Evidence for dependence of IgG-class anti-DNA antibody synthesis in the (NZB × NZW) F1 hybrid. J. Immunol. 136:1247.
28. H1 cells. Immunol. Today 14:335.
29. Finck, B. K., Chan, B. and Wofsy, D. 1994. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94:585.
30. Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S. and Howard, M. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305.
31. Jacob, C. O., van der Meide, P. H. and McDevitt, H. O. 1987. In vivo treatment of (NZB × NZW) F1 lupus-like nephritis with monoclonal antibody to γ-interferon. J. Exp. Med. 166:798.
32. Andrew, B. S., Eisenberg, R. A., Theofilopoulos, A. N. et al. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198.
33. Takahashi, S., Fossati, L., Iwamoto, M. et al. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597.
34. Izui, S., Ibnou-Zekri, N., Fossati-Jimack, L. and Iwamoto, M. 2000. Lessons from BXSB and related mouse models. Int. Rev. Immunol. 19:447.
35. Santiago, M.-L., Fossati, L., Jacquet, C., Müller, W., Izui, S. and Reininger, L. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185:65.
36. Miura-Shimura, Y., Nakamura, K., Ohtsuji, M. et al. 2002. C1q regulatory region polymorphism down-regulating murine C1q protein levels with linkage to lupus nephritis. J. Immunol. 169:1334.
37. Austyn, J. M. and Gordon, S. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805.
38. Mosley, B., Beckmann, M. P., March, C. J. et al. 1989. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335.
39. +T cell. IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl Acad. Sci. USA 94: 10838.
40. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H. 2003. The regulatory roles of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.
41. Snapperm, C. M. and Mond, J. J. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14:15.
42. Lemoine, R., Bemey, T., Shibata, T. et al. 1992. Induction of "wireloop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 41:65.
43. Hirose, S., Jiang, Y., Hamano, Y. and Shirai, T. 2000. Genetic aspects of inherent B-cell abnormalities associated with SLE and B-cell malignancy: Lessons from New Zealand mouse models. Int. Rev. Immunol. 19:389.
44. Wofsy, D., Kerger, C. E. and Seaman, W. E. 1984. Monocytosis in the BXSB model for systemic lupus erythematosus. J. Exp. Med. 159:629.
45. Merino, R., Fossati, L., Lacour, M., Lemoine, R., Higaki, M. and Izui, S. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22:295.
46. Amano, H., Amano, E., Santiago-Raber, M.-L. et al. 2005. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus. Arthritis Rheum. 52:2790.
47. Itoh, J., Nose, M., Takahashi, S. et al. 1993. Induction of diffuse types of glomerulonephritis by monoclonal antibodies derived from MRL/ Ipr lupus mouse. Am. J. Pathol. 143:1436.
48. Erb, K. J., Rüger, B., von Brevern, M., Ryffel, B., Schimpl, A. and Rivett, K. 1997. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J. Exp. Med. 185:329.
49. Hirose, S., Wakiya, M., Kawano-Nishi, Y. et al. 1993. Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. Eur. J. Immunol. 23:2813.
50. Nakajima, A., Azuma, M., Kodera, S. et al. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:3060.
51. Shirai, T. and Hirose, S. 2000. Genetics of SLE; a sine qua non for identification. Int. Rev. Immunol. 19:289.
52. Shirai, T., Nishimura, H., Jiang, Y. and Hirose, S. 2002. Genome screening for susceptibility loci in systemic lupus erythematosus. Am. J. Pharmacogenomics 2:1.